<DOC>
	<DOCNO>NCT00064987</DOCNO>
	<brief_summary>Men idiopathic hypogonadotropic hypogonadism ( IHH , Kallmann Syndrome ) may small testicular size , low testosterone level , history puberty , infertility . These men lack hormone call gonadotropin release hormone ( GnRH ) stimulate development maturation testis . This study investigate impact hormonal treatment men IHH . The goal hormonal therapy maximize potential fertility individual .</brief_summary>
	<brief_title>Follicle Stimulating Hormone ( FSH ) Improve Testicular Development Men With Hypogonadism</brief_title>
	<detailed_description>Though steroid output testis minimal childhood , important change take place impact spermatogenic potential . Specifically , number Sertoli cell increase testosterone secretion rise puberty . In animal model , proliferation Sertoli cell appear regulated follicle stimulate hormone ( FSH ) even though FSH level childhood relatively low . At puberty , number Sertoli cell become fix ; however , exist cell population undergo functional maturation . This switch proliferation maturation Sertoli cell appear result rise level intratesticular testosterone . FSH deficiency testicular development result decrease number Sertoli cell , even physiologic hormonal replacement therapy introduce adolescence adulthood . The number mature Sertoli cell appear correlate testicular size , sperm count , future fertility . An improved understanding specific role FSH , luteinizing hormone ( LH ) , testosterone testicular development may direct clinical application treatment male infertility . This study define role FSH stimulate Sertoli cell proliferation human male . Patients study randomize receive either FSH GnRH ( Group 1 ) GnRH alone ( Group 2 ) . Patients Group 1 receive subcutaneous FSH injection daily , titrate achieve FSH level 4-8 IU/L , 4 month . Patients receive GnRH therapy 18 month . GnRH administer via portable infusion pump 2-hour interval stimulate endogenous LH secretion . Patients Group 2 receive regimen exogenous GnRH 18 month without prior FSH administration . All patient undergo initial assessment include overnight 12-hour frequent blood sampling study , testicular ultrasound , testicular biopsy . Patients follow monthly study visit blood test seminal fluid analysis . Patients also serial testicular ultrasound measure testicular growth . Patients Group 1 also second frequent blood sample measure LH , FSH , testosterone confirm absence LH pulse .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Kallmann Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Inclusion Criteria history spontaneous puberty clinical hypogonadism infantile testis ( &lt; 3 ml ) reproductive hormone therapy except testosterone Complete absence normal LH pulse 12hour baseline frequent blood sample serum testosterone &lt; 100 ng/dl Normal test anterior pituitary gland Negative MRI hypothalamicpituitary area Exclusion Criteria Prior therapy gonadotropin ( FSH , hCG , GnRH )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Male reproduction hormone</keyword>
	<keyword>Hypogonadotropic hypogonadism</keyword>
	<keyword>FSH</keyword>
	<keyword>LH</keyword>
	<keyword>GnRH</keyword>
</DOC>